Conference Coverage

Treatment options for adenomyosis supported by limited high-quality data


 

EXPERT ANALYSIS FROM THE AAGL GLOBAL CONGRESS

References

And while there aren’t a lot of data out there on obstetric outcomes, the current literature suggests a 2% rate of uterine rupture even before labor and delivery. “But it doesn’t remove the uterus, so that’s something to consider,” he said. “It is an option that’s out there.”

Dr. Abbott reported that he has consulted with Bayer on the Mirena levonorgestrel intrauterine system.

msullivan@frontlinemedcom.com

Pages

Recommended Reading

Chronic insomnia afflicts one in three perimenopausal women
MDedge Internal Medicine
Midlife contraception strategy should include transition to menopause
MDedge Internal Medicine
GynePunks: A hacker’s guide to reimagining women’s health
MDedge Internal Medicine
What’s in the pipeline for female sexual problems?
MDedge Internal Medicine
Menopause status could guide breast cancer screening interval
MDedge Internal Medicine
American Cancer Society recommends annual mammography starting at age 45
MDedge Internal Medicine
Flibanserin debuts with strings attached
MDedge Internal Medicine
Denosumab better at building bone than zoledronic acid
MDedge Internal Medicine
Resistant gonorrhea rates high in China, raise concerns in U.S.
MDedge Internal Medicine
ACOG: Think of menses as a vital sign in adolescents
MDedge Internal Medicine